Declopramide: Phase I data; Phase I/II

OXGN reported interim safety data from two ongoing dose-ranging studies of declopramide plus cisplatin or 5-fluorouracil (5-FU) in patients with advanced cancers. In the 10-patient cisplatin trial, cl...